Scarica l'app Stockscreener
2.95
1.34%
-0.04
Dopo l'orario di chiusura:
2.95
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Anixa Biosciences Inc Borsa (ANIX) Ultime notizie
How to forecast Anixa Biosciences Inc. trends using time seriesJuly 2025 Outlook & Daily Volume Surge Signals - Newser
Using economic indicators to assess Anixa Biosciences Inc. potentialWeekly Trade Report & Low Risk Investment Opportunities - Newser
Tools to assess Anixa Biosciences Inc.’s risk profilePortfolio Performance Report & Reliable Entry Point Trade Alerts - Newser
Fibonacci Levels Suggest Recovery for Anixa Biosciences Inc. getLinesFromResByArray error: size == 0 - 더경남뉴스
Can a trend reversal in Anixa Biosciences Inc. lead to recoveryMarket Activity Recap & Stepwise Entry and Exit Trade Signals - Newser
Analyzing Anixa Biosciences Inc. with multi timeframe chartsProfit Target & AI Forecasted Stock Moves - Newser
Statistical indicators supporting Anixa Biosciences Inc.’s strengthGap Up & Free Fast Entry Momentum Trade Alerts - Newser
Sector ETF performance correlation with Anixa Biosciences Inc.Weekly Stock Analysis & Weekly Setup with High ROI Potential - Newser
What machine learning models say about Anixa Biosciences Inc.Market Movement Recap & AI Enhanced Trading Signals - Newser
Is Anixa Biosciences Inc. still worth holding after the dipTrade Ideas & High Accuracy Swing Entry Alerts - Newser
Is this a good reentry point in Anixa Biosciences Inc.Earnings Overview Summary & Stock Portfolio Risk Management - Newser
Risk vs reward if holding onto Anixa Biosciences Inc.2025 Top Decliners & Entry Point Confirmation Alerts - Newser
Volatility clustering patterns for Anixa Biosciences Inc.2025 Price Targets & Safe Entry Point Identification - Newser
Applying Wyckoff theory to Anixa Biosciences Inc. stockMarket Risk Summary & Fast Gain Swing Alerts - Newser
Volatility clustering patterns for Anixa Biosciences IncBreakout Watch & Verified High Yield Trade Plans - Newser
What momentum shifts mean for Anixa Biosciences Inc.2025 AllTime Highs & Technical Analysis for Trade Confirmation - Newser
Is it too late to sell Anixa Biosciences Inc.2025 Market Overview & Capital Efficiency Focused Strategies - Newser
Using RSI to spot recovery in Anixa Biosciences Inc.Portfolio Risk Report & Intraday High Probability Alerts - Newser
Anixa Biosciences to Present at the H.C. Wainwright 27th Annual Global Investment Conference - The Malaysian Reserve
Anixa Biosciences Inc. recovery potential after sell offJuly 2025 Gainers & Growth Focused Entry Reports - Newser
Anixa Biosciences shares fall 1.63% intraday as company prepares to present at H.C. Wainwright conference. - AInvest
Anixa Biosciences to Present at H.C. Wainwright 27th Annual Global Investment Conference on September 8th, 2025. - AInvest
Cancer-focused Biotech Anixa Biosciences to Present at Major H.C. Wainwright Investment Conference in NYC - Stock Titan
Detecting price anomalies in Anixa Biosciences Inc. with AIJuly 2025 Price Swings & Breakout Confirmation Alerts - Newser
Measuring Anixa Biosciences Inc.’s beta against major indicesMarket Movement Recap & Daily Oversold Stock Bounce Ideas - Newser
Multi Factor Analysis Ranks Anixa Biosciences Inc. as Strong BuyMarket Rally & Growth Focused Stock Pick Reports - beatles.ru
Can Anixa Biosciences Inc. rally from current levelsJuly 2025 Snapshot & Advanced Swing Trade Entry Plans - Newser
Quant Tools Rank Anixa Biosciences Inc. as High Risk High RewardJuly 2025 Institutional & Expert Approved Momentum Trade Ideas - 더경남뉴스
Anixa Biosciences Inc. Recovers — But Is It Sustainable2025 Stock Rankings & Expert Curated Trade Setup Alerts - beatles.ru
Anixa Biosciences, Inc Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology - MarketScreener
Anixa biosciences secures Chinese patent for breast cancer vaccine - Investing.com
Wall Street Analysts Predict a 22% Rally for NVIDIA Stock - AInvest
Anixa Biosciences Receives Notice of Allowance from Chinese National Intellectual Property Administration for Patent Covering Breast Cancer Vaccine Technology - Barchart.com
Anixa Biosciences Maintains Consistent "Buy" Rating from D. Boral Capital with $10 Price Target - AInvest
Anixa Biosciences: Buy Rating Reiterated, Price Target Raised to $10 - AInvest
Anixa Biosciences shares rise 1.89% intraday after treating second patient in fourth cohort of ovarian cancer CAR-T clinical trial. - AInvest
Anixa Biosciences treats second patient in fourth ovarian cancer trial cohort - TipRanks
Anixa Biosciences Announces Treatment of Second Patient in Fourth Cohort of Ovarian Cancer CAR-T Clinical Trial - Barchart.com
30x Dose Increase Shows No Toxicity: Anixa's Novel Ovarian Cancer CAR-T Therapy Reaches Major Milestone - Stock Titan
Can Anixa Biosciences Inc. continue delivering strong returns2025 Technical Patterns & High Return Trade Opportunity Guides - thegnnews.com
Combining price and volume data for Anixa Biosciences Inc.2025 Trade Ideas & Technical Buy Zone Confirmations - Newser
Is Anixa Biosciences Inc. benefiting from interest rate changesJuly 2025 Trade Ideas & Proven Capital Preservation Tips - thegnnews.com
Will Anixa Biosciences Inc. outperform the market in YEAR2025 Market Outlook & Fast Exit Strategy with Risk Control - thegnnews.com
0.98%
8.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):